Literature DB >> 29610850

Plasma Concentrations of Lutein and Zeaxanthin, Macular Pigment Optical Density, and Their Associations With Cognitive Performances Among Older Adults.

Soufiane Ajana1, Daniela Weber2, Catherine Helmer1, Bénédicte M Merle1, Wolfgang Stuetz3, Jean-François Dartigues1,4, Marie-Bénédicte Rougier5, Jean-François Korobelnik1,5, Tilman Grune2, Cécile Delcourt1, Catherine Féart1.   

Abstract

Purpose: We investigated the cross-sectional associations between macular pigment optical density (MPOD), plasma lutein (L), and zeaxanthin (Z) concentrations and cognitive function in 184 older adults of the 3-City-Bordeaux cohort.
Methods: MPOD was measured using the two-wavelength autofluorescence method with a modified scanning laser ophthalmoscope. Plasma L and Z (L+Z) concentrations were determined by high-performance liquid chromatography and were considered either crude or expressed as a ratio of the concentration of plasma lipids (total cholesterol [TC] + triglycerides [TG]). Cognitive performances were assessed using the following four separate neuropsychological tests: the Mini-Mental State Examination (MMSE), the Isaacs Set Test (IST), the Benton Visual Retention Test (BVRT), and the sum of the three free recalls of the Free and Cued Selective Reminding Test (FCSRT). These test results were summarized by a composite global cognitive z-score.
Results: Higher MPOD at 0.5° was significantly associated with a higher composite z-score (β = 0.15, 95% confidence interval [CI] 0.04-0.26), higher BVRT (β = 0.39, 95%CI 0.08-0.70), and higher IST (β = 1.16, 95%CI 0.11-2.22) performances. Higher plasma L+Z concentrations were significantly associated with higher IST scores (β = 0.97, 95%CI 0.01-1.94). Furthermore, a higher L+Z/TC+TG ratio was associated with a higher composite z-score (β = 0.12, 95%CI 0.01-0.23), along with higher IST (β = 1.02, 95%CI 0.002-2.04) and FCSRT (β = 1.55, 95%CI 0.41-2.69) performances. Conclusions: This analysis suggested that both higher MPOD and L+Z concentrations were significantly associated with higher cognitive performances. However, MPOD measurements have the advantage of being a fast and representative measure of long-term carotenoid intake.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29610850     DOI: 10.1167/iovs.17-22656

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Dietary carotenoids and cognitive function among US adults, NHANES 2011-2014.

Authors:  Krista Christensen; Carey E Gleason; Julie A Mares
Journal:  Nutr Neurosci       Date:  2018-10-16       Impact factor: 4.994

2.  Sex Differences Across the Life Course: A Focus On Unique Nutritional and Health Considerations among Women.

Authors:  Regan L Bailey; Tieraona Low Dog; Abbie E Smith-Ryan; Sai Krupa Das; Fiona C Baker; Zeynep Madak-Erdogan; Billy R Hammond; Howard D Sesso; Alex Eapen; Susan H Mitmesser; Andrea Wong; Haiuyen Nguyen
Journal:  J Nutr       Date:  2022-07-06       Impact factor: 4.687

3.  Effects of Lutein and Astaxanthin Intake on the Improvement of Cognitive Functions among Healthy Adults: A Systematic Review of Randomized Controlled Trials.

Authors:  Rui Nouchi; Takahiko Suiko; Eriko Kimura; Hiroki Takenaka; Michiaki Murakoshi; Akira Uchiyama; Megumi Aono; Ryuta Kawashima
Journal:  Nutrients       Date:  2020-02-27       Impact factor: 5.717

4.  The Effects of Lutein and Zeaxanthin Supplementation on Brain Morphology in Older Adults: A Randomized, Controlled Trial.

Authors:  Catherine M Mewborn; Cutter A Lindbergh; B Randy Hammond; Lisa M Renzi-Hammond; L Stephen Miller
Journal:  J Aging Res       Date:  2019-12-01

5.  Vision impairment and cognitive decline among older adults: a systematic review.

Authors:  Niranjani Nagarajan; Lama Assi; V Varadaraj; Mina Motaghi; Yi Sun; Elizabeth Couser; Joshua R Ehrlich; Heather Whitson; Bonnielin K Swenor
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 3.006

6.  The Effects of Lutein and Zeaxanthin Supplementation on Cognitive Function in Adults With Self-Reported Mild Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Adrian L Lopresti; Stephen J Smith; Peter D Drummond
Journal:  Front Nutr       Date:  2022-02-17

7.  Optimized nonionic emulsifier for the efficient delivery of astaxanthin nanodispersions to retina: in vivo and ex vivo evaluations.

Authors:  Lei Xu; Haixiang Yu; Hongbin Sun; Xiang Yu; Ye Tao
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.